In addition, amplification of the gene encoding the epithelial growth factor receptor (EGFR), a potent activator of the PI3K-Akt-mTOR pathway, observed in approximately 50% of GBMs, further underscores the importance of this pathway in glioma pathogenesis [20,21,22]. This evidence concerns the gene AKT1 and glioma.